Search Results - "Lunde, Turid Helen Felli"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    Cytokine profiling and post‐transfusion haemoglobin increment in patients with haematological diseases by Wendelbo, Øystein, Opheim, Elin Netland, Hervig, Tor, Felli Lunde, Turid Helen, Bruserud, Øystein, Mollnes, Tom Eirik, Reikvam, Håkon

    Published in Vox sanguinis (01-10-2018)
    “…Background and Objectives In a previous pilot study, we demonstrated significantly lower haemoglobin (Hb) increment after red‐blood‐cell (RBC) transfusions in…”
    Get full text
    Journal Article
  2. 2

    In vitro characteristics and in vivo platelet quality of whole blood treated with riboflavin and UVA/UVB light and stored for 24 hours at room temperature by Lunde, Turid Helen Felli, Hartson, Lindsay, Bailey, Shawn Lawrence, Hervig, Tor Audun

    Published in Transfusion (Philadelphia, Pa.) (01-07-2021)
    “…Background There is a global increase in whole blood usage and at the same time, emerging pathogens give cause for pathogen reduction technology (PRT). The…”
    Get full text
    Journal Article
  3. 3

    Cold‐stored leukoreduced CPDA‐1 whole blood: in vitro quality and hemostatic properties by Sivertsen, Joar, Braathen, Hanne, Lunde, Turid Helen Felli, Kristoffersen, Einar K., Hervig, Tor, Strandenes, Geir, Apelseth, Torunn O.

    Published in Transfusion (Philadelphia, Pa.) (01-05-2020)
    “…BACKGROUND Some jurisdictions require leukoreduction of cellular blood components. The only whole blood collection set with a platelet‐saving filter uses…”
    Get full text
    Journal Article
  4. 4
  5. 5

    In vitro quality of cold and delayed cold‐stored platelet concentrates from interim platelet units during storage for 21 days by Braathen, Hanne, Felli Lunde, Turid Helen, Assmus, Jörg, Hagen, Kristin Gjerde, Kristoffersen, Einar Klæboe, Strandenes, Geir, Apelseth, Torunn Oveland

    Published in Vox sanguinis (01-06-2023)
    “…Background and Objectives Based on previous success using apheresis platelets, we wanted to investigate the in vitro quality and platelet function in…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Effect of leukoreduction and temperature on risk of bacterial growth in CPDA‐1 whole blood: A study of Escherichia coli by Braathen, Hanne, Sivertsen, Joar, Lunde, Turid Helen Felli, Strandenes, Geir, Lindemann, Paul Christoffer, Assmus, Jörg, Hervig, Tor Audun, Apelseth, Torunn Oveland

    Published in Transfusion (Philadelphia, Pa.) (01-07-2021)
    “…Background Collection of non‐leukoreduced citrate‐phosphate‐dextrose‐adenine (CPDA‐1) whole blood is performed in walking blood banks. Blood collected under…”
    Get full text
    Journal Article
  8. 8

    Influence of platelet storage time on human platelet lysates and platelet lysate-expanded mesenchymal stromal cells for bone tissue engineering by Shanbhag, Siddharth, Mohamed-Ahmed, Samih, Lunde, Turid Helen Felli, Suliman, Salwa, Bolstad, Anne Isine, Hervig, Tor, Mustafa, Kamal

    Published in Stem cell research & therapy (23-09-2020)
    “…Background Human platelet lysate (HPL) is emerging as the preferred xeno-free supplement for the expansion of mesenchymal stromal cells (MSCs) for bone tissue…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Impact of pre-existing immunity on the induction of functional cross-reactive anti-hemagglutinin stalk antibodies following vaccination with an AS03 adjuvanted pandemic H1N1 vaccine by Tete, Sarah M., Jul-Larsen, Åsne, Rostami, Sina, Lunde, Turid Helen Felli, Søland, Hanne, Krammer, Florian, Cox, Rebecca J.

    Published in Vaccine (12-04-2018)
    “…The 2009 pandemic H1N1 (A(H1N1)pdm09) virus had a highly divergent hemagglutinin (HA) compared to pre-2009 seasonal H1N1 strains. Most peoples were…”
    Get full text
    Journal Article
  11. 11

    Blood Far Forward-a whole blood research and training program for austere environments by Strandenes, Geir, Cap, Andrew P., Cacic, Daniel, Lunde, Turid Helen Felli, Eliassen, Håkon Skogrand, Hervig, Tor, Spinella, Philip C.

    Published in Transfusion (Philadelphia, PA) (01-01-2013)
    “…The Blood Far Forward (BFF) research program was established to conduct blood product efficacy and safety studies, donor performance studies, and research on…”
    Get full text
    Journal Article Conference Proceeding
  12. 12

    Epac1-deficient mice have bleeding phenotype and thrombocytes with decreased GPIbβ expression by Nygaard, Gyrid, Herfindal, Lars, Asrud, Kathrine S., Bjørnstad, Ronja, Kopperud, Reidun K., Oveland, Eystein, Berven, Frode S., Myhren, Lene, Hoivik, Erling A., Lunde, Turid Helen Felli, Bakke, Marit, Døskeland, Stein O., Selheim, Frode

    Published in Scientific reports (18-08-2017)
    “…Epac1 (Exchange protein directly activated by cAMP 1) limits fluid loss from the circulation by tightening the endothelial barrier. We show here that Epac1 −/−…”
    Get full text
    Journal Article
  13. 13
  14. 14

    In vitro quality of cold and delayed cold‐stored platelet concentrates from interim platelet units during storage for 21days by Braathen, Hanne, Turid Helen Felli Lunde, Assmus, Jörg, Kristin Gjerde Hagen, Kristoffersen, Einar Klæboe, Strandenes, Geir, Apelseth, Torunn Oveland

    Published in Vox sanguinis (01-06-2023)
    “…Background and ObjectivesBased on previous success using apheresis platelets, we wanted to investigate the in vitro quality and platelet function in…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Cytokine profiling and post-transfusion haemoglobin increment in patients with haematological diseases by Wendelbo, Øystein, Opheim, Elin Netland, Hervig, Tor, Lunde, Turid Helen Felli, Bruserud, Øystein, Mollnes, Tom Eirik, Reikvam, Håkon

    Published in Vox sanguinis (2018)
    “…Background and Objectives: In a previous pilot study, we demonstrated significantly lower haemoglobin (Hb) increment after red‐blood‐cell (RBC) transfusions in…”
    Get full text
    Journal Article
  17. 17

    Blood F ar F orward—a whole blood research and training program for austere environments by Strandenes, Geir, Cap, Andrew P., Cacic, Daniel, Lunde, Turid Helen Felli, Eliassen, Håkon Skogrand, Hervig, Tor, Spinella, Philip C.

    Published in Transfusion (Philadelphia, Pa.) (01-01-2013)
    “…The B lood F ar F orward ( BFF ) research program was established to conduct blood product efficacy and safety studies, donor performance studies, and research…”
    Get full text
    Journal Article